Reed Smith offices in Washington, D.C. Photo by Diego M. Radzinschi/NLJ
A Chicago federal jury awarded $3 million to the widow of lawyer Stewart Dolin after finding GlaxoSmithKline was liable for his suicide. An appeals court overturned that decision, and the justices have denied review.
May 28, 2019 at 10:29 AM
1 minute read
The original version of this story was published on National Law Journal
The U.S. Supreme Court on Tuesday denied certiorari review in a high-profile case involving the suicide of a Reed Smith partner in 2010, an outcome that favors GlaxoSmithKline, the pharmaceutical company whose antidepressant drug was targeted as a cause of his death.
In 2017, a Chicago federal jury awarded $3 million to the widow of lawyer Stewart Dolin after finding that GlaxoSmithKline was liable for his suicide. He was taking a generic version of the company’s drug Paxil.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
